The platelet rich plasma market is slated to clock a robust CAGR of 11.2% during the forecast period and to reach the valuation of US$ 815.3 Mn by 2030.
The platelet rich plasma market is slated to clock a robust CAGR of 11.2% during the forecast period and to reach the valuation of US$ 815.3 Mn by 2030.
Research studies from Indonesia are grabbing the attention of stakeholders in the platelet rich plasma market. Due to the increasing number of COVID-19 cases in Indonesia, autologous activated platelet-rich plasma (aaPRP) has been gaining recognition for potentials in suppressing cytokine release syndrome (CRS) in patients. Since cytokine storm has been a typical symptom among coronavirus patients in Indonesia, intravenous autologous activated platelet-rich plasma holds promising potentials to reduce death rates.
Download Sample @ https://qyresearchmedical.com/sample/111502
Postponement and rescheduling of medical treatments have affected revenue flow in the platelet rich plasma market during the ongoing pandemic. Nevertheless, companies are implementing comprehensive vendor reviews to ensure robust medical supplies at healthcare facilities. They are reviewing processes for monitoring expiration dates and replace old supplies with new ones.
Need for Official FDA Approval in End-use Cases Hampers Market Growth
The platelet rich plasma market is expected to reach the valuation of US$ 815.3 Mn by 2031. Although the equipment used to produce PRP and the injections have been cleared by the FDA (Food and Drug Administration), this procedure is considered investigational and has not been officially approved by the FDA for many uses. Nevertheless, PRP is a low-risk procedure and linked with minor side effects.
Outside of the orthopedic treatment, PRP is being used for the treatment of hair loss, for skin rejuvenation, and post-surgical healing. Healthcare companies are establishing stable revenue streams with the help of PRP injections meant for tendon, muscle, and join injuries.
Dramatic Skin Improvement with Cosmetic PRP Creating Revenue Opportunities
The platelet rich plasma market is slated to clock a robust CAGR of 11.2% during the forecast period. The American Society of Plastic Surgeons has been witnessing a significant increase in the use of cosmetic PRP in the past few years. This is evident, as treatments using PRP show great promise for harnessing the body’s own natural tissue repair processes to help patients achieve improved form and function.
Platelet rich plasma is being prepared by manufacturers in the platelet rich plasma market with the help of various methods such as centrifugation, which involves spinning a small sample of the patient’s blood into separate components, followed by other steps. The growing popularity of vampire facial consisting of non-surgical microneedling followed by topical application of PRP is creating revenue opportunities for market stakeholders.
PRP Improves Patient Quality of Life with Prevention of Orthopedic Surgery
Since PRP mimics the body’s natural healing process, companies in the platelet rich plasma market are tapping incremental opportunities in orthopedics. Increased levels of platelets lead to increased growth factors, which have the potential to improve signaling and recruitment of cells to promote quicker & efficient healing in complex orthopedic conditions in patients.
AOA Orthopedic Specialists has been gaining recognition for increasing the availability of PRP in order to either delay or prevent an orthopedic surgery or to use in conjunction with the surgery.
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111502/2900
Analysts’ Viewpoint
As pharmaceutical and life sciences companies make changes to supply chains, stakeholders in the platelet rich plasma market are revisiting key assumptions in financial projections, owing to potential supply chain disruptions. PRP is gaining prominence in plastic surgery. However, for cosmetic procedures, the treatment can be potentially time consuming and may require multiple session, leading to high costs. Hence, stakeholders should increase awareness about the advantages of cosmetic PRP that shows dramatic improvements in skin contour. As such, PRP is being deployed for orthopedic conditions such as knee arthritis and promote healing after an orthopedic surgery. Companies in the platelet rich plasma market are enhancing their production capabilities to produce PRP for treatment of chronic tendon injuries, acute ligament injuries and fractures amongst others.
Platelet Rich Plasma Market: Overview
This report analyzes the current scenario and future prospects of the global platelet rich plasma market. Increase in awareness about platelet rich plasma therapies, rise in prevalence of various orthopedic diseases, and surge in demand for effective hair-loss treatment are the key factors projected to propel the global platelet rich plasma market during the forecast period.
Advantages and applications of PRP therapy over conventional wound healing and disease treatments, such as surgery and medicines, have resulted in higher demand for PRP products globally
The report includes an elaborate executive summary, which provides a snapshot of various segments of the global platelet rich plasma market. It also provides information and data analysis of the platelet rich plasma market based on type, origin, application, and region
The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global platelet rich plasma market
The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global platelet rich plasma market
The report on the platelet rich plasma market offers market attractiveness analysis of regions and segments
The last section of the report comprises quantitative and qualitative analysis of market share/position of key players operating in the global platelet rich plasma market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global platelet rich plasma market.
Platelet Rich Plasma Market: Key Segments
In terms of sample type, the global platelet rich plasma market has been classified pure PRP, leukocyte-rich PRP, and pure PRF. The pure PRP segment is projected to account for major share of the global platelet rich plasma market in the near future. The segment’s dominance can be ascribed to technological advancements of PRP devices leading to the use of pure PRP in various cases and rich platelet content are anticipated to boost the growth of the segment in the next few years. Technological advancements such as smart home diagnostic kits has also boosted the growth of the global market.
Based on origin, the global platelet rich plasma market has been categorized into autologous, allogenic, and homologus. The autologous segment dominated the global platelet rich plasma market in 2020. Autologous PRP is a safe, simple, and cost-efficient approach and has positive effect on cell proliferation, migration, and angiogenesis. Autologous PRP is quite beneficial in the treatment of chronic non-healing ulcers. This is expected to drive the demand for autologous PRP, especially in developed countries across the globe.
In terms of application, the global platelet rich plasma market has been segregated into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, and others. The orthopedic surgery is likely to account for major share of the global platelet rich plasma market during the forecast period. Rise in the number of orthopedic surgeries is projected to drive the segment during of the forecast period.
CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year
Platelet Rich Plasma Market: Regional Outlook
In terms of region, the global platelet rich plasma market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, Switzerland, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
The platelet rich plasma market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The platelet rich plasma market study also covers the competitive scenario across the globe.
Companies Covered in Platelet Rich Plasma Market Report
Key players operating in the global platelet rich plasma market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
Major companies profiled in the platelet rich plasma market report are
- SelfDiagnostics
- F. Hoffmann-La Roche Ltd.
- Trinity Biotech plc
- Bionime Corporation
- ARKRAY, Inc.
- ACON Laboratories, Inc.
- Assure Tech. (Hangzhou) Co., Ltd.
- Abbott
- Becton
- Dickinson and Company
- Quidel Corporation
Key Questions Answered in Platelet Rich Plasma Market Report
- What is the revenue forecast for the global platelet rich plasma market in terms of revenue for the period 2021–2031?
- How would various dynamics such as drivers, restraints, opportunities, and trends affect the market?
- What is the market size and estimation for the platelet rich plasma market across regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa?
- Which regional market is poised to expand at a significant CAGR during the forecast period?
- Which type segment is projected to generate considerable revenue in 2031 and which application segment will register the fastest CAGR during the forecast period?
Platelet Rich Plasma Market – Segmentation
Type
- Pure-PRP
- Leukocyte-rich PRP
- Pure-PRF
Origin
- Autologous
- Allogeneic
- Homologous
Application
- Orthopedic Surgery
- Cosmetic Surgery
- General Surgery
- Neurosurgery
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111502/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/